MedPath

Die Bedeutung des sensorischen Nervensystems für die Repigmentierung der Haut bei Vitiligo(engl.: The role of the sensory nervous system for repigmentation in vitiligo)

Phase 1
Conditions
Vitiligo
Registration Number
EUCTR2006-000838-12-AT
Lead Sponsor
Peter Wolf MD, Department of Dermatology, Medical University of Graz
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
15
Inclusion Criteria

Patients with Vitiligo
Vitiligo for more than 6 months
Age > 18 years

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Present or past Malignant Melanoma or
Autoimmundiseases (Lupus erythemathosus, Dermatomyositis)
Immundeficiency
Systemic Treatment with corticosteroids and/or other immunosuppressive drugs
Pregnancy or Lactation
UV-treatment of the vitiliginous skin areas under investigation within last 2 weeks
Significant Reduction in general health condition

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath